# US 2012/0253298 A1 · Layered tissue thickness compensator

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0253298 A1
- Document ID: US20120253298A1
- Status: Published application
- Kind: A1
- Application number: 13/433,175
- Filed: 2012-03-28
- Published: 2012-10-04
- Earliest claimed: 2010-09-30
- Assignees: Ethicon Endo-Surgery, Inc.
- Inventors: Cortney E. Henderson; Taylor W. Aronhalt; Chunlin Yang; Charles J. Scheib; Venkataramanan Mandakolathur Vasudevan; Mark D. Timmer; Richard W. Timm; Tamara Widenhouse; Steven G. Hall
- Web page: https://patentgrep.com/patent/US20120253298A1

## CPC

- A61B 17/00491: {Surgical glue applicators}
- A61B 17/064: Surgical staples, {i.e. penetrating the tissue}
- A61B 17/0643: {with separate closing member, e.g. for interlocking with staple}
- A61B 17/0644: {penetrating the tissue, deformable to closed position}
- A61B 17/068: Surgical staplers {, e.g. containing multiple staples or clamps}({staplers containing only one staple A61B17/10; magazines or containers for staples A61B17/105;} for performing anastomosis A61B17/115; {staplers in general B25C5/00})
- A61B 17/072: for applying a row of staples in a single action, e.g. the staples being applied simultaneously
- A61B 17/07207: {the staples being applied sequentially}
- A61B 17/07292: {Reinforcements for staple line, e.g. pledgets}
- A61B 17/105: {Wound clamp magazines (for packaging sharps A61B50/3001)}
- A61B 17/1155: {Circular staplers comprising a plurality of staples}
- A61B 17/30: Surgical pincettes, i.e. surgical tweezers {without pivotal connections (for holding suture needles or materials A61B17/0483)}
- A61P 17/02: for treating wounds, ulcers, burns, scars, keloids, or the like
- A61B 17/2909: {Handles}
- A61B 2017/00004: {(bio)absorbable, (bio)resorbable or resorptive}
- A61B 2017/00495: {for two-component glue}
- A61B 2017/00526: {Methods of manufacturing}
- A61B 2017/0053: {Loading magazines or sutures into applying tools}
- A61B 2017/00818: {Treatment of the gastro-intestinal system}
- A61B 2017/00884: {enhancing wound closure}
- A61B 2017/00893: {pharmaceutically effective}
- A61B 2017/00991: {Telescopic means}
- A61B 2017/07228: {Arrangement of the staples}
- A61B 2017/07235: {containing different staples, e.g. staples of different shapes, sizes or materials}
- A61B 2017/07242: {achieving different staple heights during the same shot, e.g. using an anvil anvil having different heights or staples of different sizes}
- A61B 2017/0725: {with settable gap between anvil and cartridge, e.g. for different staple heights at different shots}
- A61B 2017/07257: {characterised by its anvil}
- A61B 2017/07264: {characterised by its staple forming cavities, e.g. geometry or material}
- A61B 2017/07271: {characterised by its cartridge}
- A61B 2017/07278: {characterised by its sled or its staple holder}
- A61B 2017/07285: {characterised by its cutter}
- A61B 2017/2908: {Multiple segments connected by articulations}
- A61B 2017/2916: {pins in guiding slots}
- A61B 2017/2919: {details of linkages or pivot points}
- A61B 2017/2923: {Toothed members, e.g. rack and pinion}
- A61B 2017/2927: {the angular position of the head being adjustable with respect to the shaft}
- A61B 2017/2933: {camming or guiding means}
- A61B 2017/2936: {Pins in guiding slots}
- A61B 2017/2937: {with flexible part}
- A61B 2017/320052: {Guides for cutting instruments}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

A tissue thickness compensator may generally comprise a first layer comprising a first medicament, a second layer comprising a second medicament, and a third layer comprising a third medicament. The tissue thickness compensator may comprise a first layer comprising a first medicament, a second layer comprising a second medicament, and a reservoir comprising a third medicament disposed within the reservoir. The medicaments may be independently selected from a haemostatic agent, an anti-inflammatory agent, an antibiotic agent, anti-microbial agent, an anti-adhesion agent, an anti-coagulant agent, a pharmaceutically active agent, a matrix metalloproteinase inhibitor, and combinations thereof. Articles of manufacture comprising the tissue thickness compensator and methods of making and using the tissue thickness compensator are also described.

## Claims

### Claim 1

A tissue thickness compensator comprising:
a first layer comprising a first medicament;
a second layer comprising a second medicament; and
a third layer comprising a third medicament disposed between the first layer and the second layer.

### Claim 2 (depends on 1)

The tissue thickness compensator of claim 1, wherein the first medicament, second medicament, and third medicament are independently selected from a haemostatic agent, an anti-inflammatory agent, an antibiotic agent, anti-microbial agent, an anti-adhesion agent, an anti-coagulant agent, a pharmaceutically active agent, a matrix metalloproteinase inhibitor, and combinations thereof.

### Claim 3 (depends on 1)

The tissue thickness compensator of claim 1, wherein the first medicament comprises a haemostatic agent, the second medicament comprises an anti-adhesion agent, and the third medicament comprises a matrix metalloproteinase inhibitor.

### Claim 4 (depends on 1)

The tissue thickness compensator of claim 1, wherein the first layer comprises a first film comprising a haemostatic agent, the second layer comprises a second film comprising an anti-adhesion agent, and the third layer comprises a biocompatible foam having a matrix metalloproteinase inhibitor homogeneously distributed therein.

### Claim 5 (depends on 4)

The tissue thickness compensator of claim 4, wherein the first film is mechanically bonded to the biocompatible foam.

### Claim 6 (depends on 1)

The tissue thickness compensator of claim 1, wherein the first layer, second layer, and third layer are independently selected from polylactides, poly(lactic acid), polyglycolides, poly(glycolic acid), poly(trimethylene carbonate), poly(dioxanone), poly(hydroxybutyric acid), poly(hydroxyvaleric acid), poly(lactide-co-(ε-caprolactone)), poly(glycolide-co-(ε-caprolactone)), poly(lactic-co-glycolic acid), polycarbonates, poly(pseudo amino acids), poly(amino acids), poly(hydroxyalkanoate)s, polyalkylene oxalates, polyoxaesters, polyanhydrides, polyortho esters, and copolymers, block copolymers, homopolymers, blends, and combinations thereof.

### Claim 7 (depends on 1)

The tissue thickness compensator of claim 1, wherein the first layer comprises a biodegradable polymer, and the third medicament elutes from the third layer when the first layer degrades.

### Claim 8 (depends on 1)

The tissue thickness compensator of claim 1, wherein the first layer comprises at least one of the second medicament and third medicament.

### Claim 9 (depends on 1)

The tissue thickness compensator of claim 1, wherein the first layer comprises collagen, gelatin, thrombin, fibrin, fibrinogen, fibronectin, elastin, albumin, hemoglobin, ovalbumin, polysaccharides, hyaluronic acid, chondroitin sulfate, hydroxyethyl starch, hydroxyethyl cellulose, cellulose, oxidized cellulose, hydroxypropyl cellulose, carboxyethyl cellulose, carboxymethyl cellulose, chitan, chitosan, agarose, maltose, maltodextrin, alginate, clotting factors, methacrylate, polyurethanes, cyanoacrylates, platelet agonists, vasoconstrictors, alum, calcium, RGD peptides, proteins, protamine sulfate, ε-amino caproic acid, ferric sulfate, ferric subsulfates, ferric chloride, zinc, zinc chloride, aluminum chloride, aluminum sulfates, aluminum acetates, permanganates, tannins, bone wax, polyethylene glycols, fucans and combinations thereof.

### Claim 10 (depends on 1)

The tissue thickness compensator of claim 1, wherein the second layer comprises poly(vinyl pyrrolidone), carboxymethyl cellulose, hyaluronic acid, polyethylene oxide, poly vinyl alcohols, doxycycline, diclofenac, aspirin, naproxen, sulindac, hydrocortisone, and combinations thereof.

### Claim 11 (depends on 1)

The tissue thickness compensator of claim 1, wherein the second layer comprises one of a powder, a gel, and a fluid.

### Claim 12

A tissue thickness compensator comprising:
a first layer comprising a first medicament;
a second layer comprising a second medicament; and
a reservoir comprising a third medicament disposed within the reservoir.

### Claim 13 (depends on 12)

The tissue thickness compensator of claim 12, wherein the first medicament, second medicament, and third medicament are independently selected from a haemostatic agent, an anti-inflammatory agent, an antibiotic agent, anti-microbial agent, an anti-adhesion agent, an anti-coagulant agent, a pharmaceutically active agent, a matrix metalloproteinase inhibitor, and combinations thereof.

### Claim 14 (depends on 12)

The tissue thickness compensator of claim 12, wherein the third medicament comprises one of a powder, a gel, and a fluid.

### Claim 15 (depends on 12)

The tissue thickness compensator of claim 12, wherein the first layer comprises an outer layer comprising one of a haemostatic agent and an anti-adhesion agent, the second layer comprises an inner layer comprising a biocompatible foam having the second medicament dispersed therein, and the reservoir comprises a polymeric fluid disposed therein.

### Claim 16

A medicament delivery system comprising:
an inner layer;
a reservoir comprising at least one regenerative medicament; and
an outer layer comprising a porous surface configured to receive at least one of bone and tissue ingrowth therein;
wherein the outer layer is in fluid communication with the reservoir.

### Claim 17 (depends on 16)

The system of claim 16 comprising an inlet port in fluid communication with the reservoir and configured to convey the at least one regenerative medicament from the inlet port to the reservoir, and at least one channel fluidly communicating the reservoir with the outer layer to deliver the at least one regenerative medicament to a treatment site.

### Claim 18 (depends on 16)

The system of claim 16, wherein the inner layer and outer layer are independently selected from albumin, alginate, carbohydrate, casein, cellulose, chitin, chitosan, collagen, blood, dextran, elastin, fibrin, fibrinogen, gelatin, heparin, hyaluronic acid, keratin, protein, serum, starch, polylactides, poly(lactic acid), polyglycolides, poly(glycolic acid), poly(trimethylene carbonate), poly(dioxanone), poly(hydroxybutyric acid), poly(hydroxyvaleric acid), poly(lactide-co-(ε-caprolactone)), poly(glycolide-co-(ε-caprolactone)), poly(lactic-co-glycolic acid), polycarbonates, poly(pseudo amino acids), poly(amino acids), poly(hydroxyalkanoate)s, polyalkylene oxalates, polyoxaesters, polyanhydrides, polyortho esters, and copolymers, block copolymers, homopolymers, blends, and combinations thereof.

### Claim 19 (depends on 16)

The system of claim 16, wherein the at least one medicament is selected from the group consisting of stem cells, platelet rich plasma, DNA, RNA, enzymes, growth factors, peptides, polypeptides, antibodies, and combinations thereof.

### Claim 20 (depends on 16)

The system of claim 16, wherein the inner layer comprises a biodegradable foam, the at least one regenerative medicament comprises stem cells and growth factors, and the outer layer comprises a collagen film.

### Claim 21

A tissue thickness compensator configured to redistribute compressive forces applied to the tissue thickness compensator, the tissue thickness compensator comprising:
a compressible core comprising:
a semi-rigid, bioabsorbable particle; and
a compressible, bioabsorbable particle; and
a wrap surrounding the compressible core.

### Claim 22 (depends on 21)

The tissue thickness compensator of claim 21, wherein the compressible core comprises a microsphere particle comprising at least one medicament.

### Claim 23 (depends on 21)

The tissue thickness compensator of claim 21, wherein the compressible core comprises albumin, alginate, carbohydrate, casein, cellulose, chitin, chitosan, collagen, blood, dextran, elastin, fibrin, fibrinogen, gelatin, heparin, hyaluronic acid, keratin, protein, serum, starch, poly(lactic acid), poly(glycolic acid), poly(hydroxybutyrate), poly(phosphazine), polyesters, polyethylene glycols, polyalkyleneoxides, polyacrylamides, polycarbonates, polyhydroxyethylmethylacrylate, poly(vinylpyrrolidone), polyvinyl alcohols, poly(caprolactone), poly(dioxanone), polyacrylic acid, polyacetate, polypropylene, glycerols, poly(amino acids), copoly(ether-esters), polyalkylene oxalates, polyamides, poly(iminocarbonates), polyoxaesters, polyorthoesters, polyphosphazenes and combinations thereof.

### Claim 24 (depends on 21)

The tissue thickness compensator of claim 21, wherein the wrap comprises poly(lactic acid), poly(glycolic acid), poly(hydroxybutyrate), poly(phosphazine), polyesters, polyethylene glycols, polyalkyleneoxides, polyacrylamides, polycarbonates, polyhydroxyethylmethylacrylate, poly(vinylpyrrolidone), polyvinyl alcohols, poly(caprolactone), poly(dioxanone), polyacrylic acid, polyacetate, polypropylene, glycerols, poly(amino acids), copoly(ether-esters), polyalkylene oxalates, polyamides, poly(iminocarbonates), polyoxaesters, polyorthoesters, polyphosphazenes and combinations thereof.

### Claim 25 (depends on 21)

The tissue thickness compensator of claim 21, wherein the at least one medicament is selected from a haemostatic agent, an anti-inflammatory agent, an antibiotic agent, anti-microbial agent, an anti-adhesion agent, an anti-coagulant agent, a pharmaceutically active agent, a matrix metalloproteinase inhibitor, and combinations thereof.
